These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24476990)

  • 1. Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management.
    Macedo FI; Faris J; Lum LG; Gabali A; Uberti JP; Ratanatharathorn V; White MT
    J Burn Care Res; 2014; 35(6):e431-5. PubMed ID: 24476990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation.
    Jeanmonod P; Hubbuch M; Grünhage F; Meiser A; Rass K; Schilling MK; Kollmar O
    Transpl Infect Dis; 2012 Aug; 14(4):422-6. PubMed ID: 22650490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed presentation of toxic epidermal necrolysis-like cutaneous acute graft-versus-host disease in the setting of recent immunosuppressant discontinuation.
    Goyal PKK; Xu S; Choi J
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis-like acute graft-versus-host disease in pediatric bone marrow transplant patients: Case series and review of the literature.
    Sheu Song J; Huang JT; Fraile Alonso MDC; Antaya RJ; Price HN; Funk T; Francois RA; Shah SD
    Pediatr Dermatol; 2022 Nov; 39(6):889-895. PubMed ID: 35730149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin.
    Chen A; Chao K; Rodriguez L; Munday W; Worswick S
    Leuk Lymphoma; 2018 Sep; 59(9):2261-2263. PubMed ID: 29322835
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic epidermal necrolysis in a child 6 months post-hematopoietic stem cell transplantation.
    Oba U; Yamada H; Suenobu SI; Nakamura Y; Ito A; Hatano Y; Itonaga N; Ohshima K; Koga Y; Ohga S; Ihara K
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28497658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic Epidermal Necrolysis-like Reaction After Hematopoietic Stem Cell Transplantation in Children.
    Faraci M; Giardino S; Lanino E; Morreale G; Ghibaudo E; Francesia Berta M; Risso M; Castagnola E; Ripaldi M; Moscatelli A; Ghigliotti G
    J Pediatr Hematol Oncol; 2017 May; 39(4):254-258. PubMed ID: 28267083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic Epidermal Necrolysis vs. Acute Cutaneous Graft Versus Host Disease after Hematopoietic Stem Cell Transplantation: A Diagnostic and Therapeutic Challenge.
    Rodríguez Tejero A; Badiola González J; Roldán Mateo L; Molina Leyva A
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):81-82. PubMed ID: 32986973
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation.
    Takeda H; Mitsuhashi Y; Kondo S; Kato Y; Tajima K
    J Dermatol; 1997 Oct; 24(10):635-41. PubMed ID: 9375462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host Disease and Toxic Epidermal Necrolysis Following Hematopoietic Stem Cell Transplantation.
    Vera N; Lewis S; Seminario-Vidal L
    Cutis; 2022 Feb; 109(2):E9-E12. PubMed ID: 35659813
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
    Schwartz RA; McDonough PH; Lee BW
    J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma.
    Stone N; Sheerin S; Burge S
    Clin Exp Dermatol; 1999 Jul; 24(4):260-2. PubMed ID: 10457124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysis.
    Correia O; Delgado L; Barbosa IL; Domingues JC; Azevedo R; Vaz CP; Pimentel P
    Dermatology; 2001; 203(3):212-6. PubMed ID: 11701973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advancement in the diagnosis and management of toxic epidermal necrolysis].
    Sun W; Min D; Guo G
    Zhonghua Shao Shang Za Zhi; 2016 Jun; 32(6):341-4. PubMed ID: 27321487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.
    Cogbill CH; Drobyski WR; Komorowski RA
    Mod Pathol; 2011 Jan; 24(1):117-25. PubMed ID: 20953169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case report; differential diagnosis of post-transfusion graft-versus-host disease in a case with toxic epidermal necrolysis].
    Ohyagi H; Kume M; Takahashi N; Sawada K
    Nihon Naika Gakkai Zasshi; 2013 Jun; 102(6):1467-9. PubMed ID: 23947216
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
    Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
    J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening graft-vs-host disease.
    Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
    Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of toxic epidermal necrolysis occurring after bone marrow transplantation accompanied by engraftment failure.
    Asai C; Watanabe Y; Mukaijo J; Takamura N; Okawa T; Yamaguchi Y; Matsumura A; Matsumoto K; Aihara M
    J Dermatol; 2019 Jun; 46(6):540-543. PubMed ID: 31106904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-vs-host disease following allogeneic hematopoietic cell transplantation.
    Pidala J
    Cancer Control; 2011 Oct; 18(4):268-76. PubMed ID: 21976245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.